TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biognos AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
12
|
96
|
96 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-116
|
-27
|
-43 |
| EBITDA |
-114
|
-24
|
-39 |
| Total assets |
52
|
51
|
70 |
| Current assets |
52
|
48
|
64 |
| Current liabilities |
34
|
42
|
63 |
| Equity capital |
18
|
9
|
7 |
| - share capital |
9
|
10
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
34.6%
|
17.6%
|
10.0% |
| Turnover per employee |
12
|
96
|
96 |
| Profit as a percentage of turnover |
-966.7%
|
-28.1%
|
-44.8% |
| Return on assets (ROA) |
-223.1%
|
-52.9%
|
-61.4% |
| Current ratio |
152.9%
|
114.3%
|
101.6% |
| Return on equity (ROE) |
-644.4%
|
-300%
|
-614.3% |
| Change turnover |
-76
|
1
|
0 |
| Change turnover % |
-87%
|
1%
|
0% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.